Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | BMY | AMGN | REGN | VRTX |
| Company | Gilead Sciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 67.37 | 47.92 | 272.81 | 906.90 | 404.50 |
| High | 67.37 | 47.92 | 272.81 | 915.70 | 406.83 |
| Low | 67.37 | 47.92 | 272.81 | 904.41 | 399.29 |
| Last | 67.37 | 47.92 | 272.81 | 906.54 | 400.76 |
| Change | +0.29 | -0.94 | -0.20 | -0.78 | -4.15 |
| % Change | +0.43% | -1.92% | -0.07% | -0.09% | -1.02% |
| Volume | 2,549 | 160,425 | 403 | 373,700 | 806,400 |
| 20-Day Average Volume | 6,103,288 | 10,613,251 | 2,059,910 | 441,820 | 970,000 |
| Previous Close | 67.08 | 48.86 | 273.01 | 907.32 | 404.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 68.79 | 50.10 | 270.87 | 926.29 | 403.29 |
| 20-Day Raw Stochastic | 18.44% | 4.45% | 43.50% | 18.66% | 32.03% |
| 20-Day Relative Strength | 34.89% | 37.33% | 47.98% | 39.46% | 44.82% |
| Weighted Alpha | -20.30 | -27.99 | +11.04 | +13.86 | +16.09 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 24% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 88% Sell | 8% Sell | 24% Buy | 80% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.83% since 04/18/24 | -0.79% since 04/18/24 | +3.83% since 04/18/24 | +0.59% since 04/17/24 | +1.95% since 04/17/24 |
| Low | 66.16 on 04/19/24 | 47.92 on 04/25/24 | 260.68 on 04/19/24 | 891.46 on 04/19/24 | 391.01 on 04/18/24 |
| High | 67.68 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 920.73 on 04/19/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -7.18% since 03/25/24 | -8.29% since 03/25/24 | -2.85% since 03/25/24 | -6.28% since 03/22/24 | -3.58% since 03/22/24 |
| Low | 65.90 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 391.01 on 04/18/24 |
| High | 73.87 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 976.75 on 03/27/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -16.03% since 01/25/24 | -3.41% since 01/25/24 | -12.07% since 01/25/24 | -4.40% since 01/24/24 | -6.27% since 01/24/24 |
| Low | 65.90 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 890.43 on 04/16/24 | 391.01 on 04/18/24 |
| High | 80.51 on 01/26/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -14.06% since 10/25/23 | -15.35% since 10/25/23 | +0.24% since 10/25/23 | +12.71% since 10/24/23 | +8.50% since 10/24/23 |
| Low | 65.90 on 04/18/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 769.19 on 10/27/23 | 341.90 on 11/16/23 |
| High | 87.86 on 01/19/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 998.33 on 02/28/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 83,519,768 | 99,027,448 | 146,436,016 | 99,503,640 | 103,580,040 |
| Shares Outstanding, K | 1,245,077 | 2,026,759 | 536,376 | 109,762 | 258,459 |
| Annual Sales | 27,116,000,000 | 45,006,000,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 |
| Annual Net Income | 5,665,000,000 | 8,025,000,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 |
| Last Quarter Sales | 7,114,000,000 | 11,477,000,000 | 8,196,000,000 | 3,434,300,000 | 2,517,700,000 |
| Last Quarter Net Income | 1,429,000,000 | 1,762,000,000 | 767,000,000 | 1,159,600,000 | 968,800,000 |
| 60-Month Beta | 0.19 | 0.39 | 0.58 | 0.11 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.72 on 02/06/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 11.86 on 02/02/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/25/24 | 04/25/24 | 05/02/24 | 05/02/24 | 05/06/24 |
| Most Recent Dividend | 0.770 on 03/14/24 | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | N/A |
| Next Ex-Dividends Date | 03/14/24 | 04/04/24 | 05/16/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 9.97 | 6.53 | 14.67 | 24.14 | 30.13 |